218 related articles for article (PubMed ID: 20135088)
1. Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care.
Bertram MY; Lim SS; Barendregt JJ; Vos T
Diabetologia; 2010 May; 53(5):875-81. PubMed ID: 20135088
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore.
Png ME; Yoong JS
PLoS One; 2014; 9(9):e107225. PubMed ID: 25203633
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
Trials; 2015 Nov; 16():496. PubMed ID: 26530718
[TBL] [Abstract][Full Text] [Related]
5. Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained.
Olchanski N; van Klaveren D; Cohen JT; Wong JB; Ruthazer R; Kent DM
Acta Diabetol; 2021 Jun; 58(6):707-722. PubMed ID: 33517494
[TBL] [Abstract][Full Text] [Related]
6. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.
Diabetes Prevention Program Research Group
Diabetes Care; 2012 Apr; 35(4):723-30. PubMed ID: 22442395
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
Eddy DM; Schlessinger L; Kahn R
Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
[TBL] [Abstract][Full Text] [Related]
8. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
Diabetes Prevention Program Research Group
Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
[TBL] [Abstract][Full Text] [Related]
9. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review.
Zhou X; Siegel KR; Ng BP; Jawanda S; Proia KK; Zhang X; Albright AL; Zhang P
Diabetes Care; 2020 Jul; 43(7):1593-1616. PubMed ID: 33534726
[TBL] [Abstract][Full Text] [Related]
11. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.
Roberts S; Barry E; Craig D; Airoldi M; Bevan G; Greenhalgh T
BMJ Open; 2017 Nov; 7(11):e017184. PubMed ID: 29146638
[TBL] [Abstract][Full Text] [Related]
12. Prevention of diabetes: a strategic approach for individual patients.
Shin JA; Lee JH; Kim HS; Choi YH; Cho JH; Yoon KH
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():79-84. PubMed ID: 23280871
[TBL] [Abstract][Full Text] [Related]
13. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
Palmer AJ; Roze S; Valentine WJ; Spinas GA; Shaw JE; Zimmet PZ
Clin Ther; 2004 Feb; 26(2):304-21. PubMed ID: 15038953
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of a Stepwise Approach vs Standard Care for Diabetes Prevention in India.
Islek D; Weber MB; Ranjit Mohan A; Mohan V; Staimez LR; Harish R; Narayan KMV; Laxy M; Ali MK
JAMA Netw Open; 2020 Jul; 3(7):e207539. PubMed ID: 32725244
[TBL] [Abstract][Full Text] [Related]
15. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
Palmer AJ; Tucker DM
Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
[TBL] [Abstract][Full Text] [Related]
16. Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case study.
Al-Omar HA; Czech M; Quang Nam T; Gottwald-Hostalek U; Vesic N; Whitehouse J; Dawson M
J Diabetes; 2024 May; 16(5):e13553. PubMed ID: 38664882
[TBL] [Abstract][Full Text] [Related]
17. Summaries for patients. The cost-effectiveness of strategies to prevent type 2 diabetes.
Ann Intern Med; 2005 Mar; 142(5):I28. PubMed ID: 15738446
[No Abstract] [Full Text] [Related]
18. An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study.
Liu X; Li C; Gong H; Cui Z; Fan L; Yu W; Zhang C; Ma J
BMC Public Health; 2013 Aug; 13():729. PubMed ID: 23919839
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA
Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
